Snapshot · The Rest Is Politics
The UK accounts for only 1% of global direct emissions and the EU for only 7%, raising questions about whether European climate leadership can meaningfully affect the global trajectory.
Where this was said
At 53:20 · chapter starts 50:23
With Jørgensen gone, Rory and Alastair engage in what is arguably the most intellectually honest exchange of the episode. Rory Stewart's verdict is uncomfortable: the reason the green transition argument is losing public ground is not a conspiracy by Trump or the far right — it is because ordinary businesses and households sense that the 'green energy is cheap energy' narrative doesn't fully add up. He notes that a German industrialist listening to Jørgensen would be tearing their hair out. [1] — Rory Stewart "After the interview, Rory and Alastair disagree sharply. Rory argues that insisting green energy is always cheap and that there are no trad…" 49:48 Alastair Campbell pushes back hard: a Business Breakthrough Barometer survey shows 92% of European business leaders see competitive advantage in the renewables approach; the political problem is not the economics but the right-left polarisation of the debate, exploited by figures like Richard Tice and the Reform Party. He is also critical of Tony Blair's recent signals on North Sea drilling, despite praising the Tony Blair Institute's climate papers as among the best Jørgensen has read. The exchange ends with Rory calling for global solutions — taxing embedded carbon in imports from China — and Alastair insisting that dismissing the 1% European contribution as futile is itself part of the problem.
A Business Breakthrough Barometer survey of European business leaders found 92% see competitive advantage in the renewables-focused approach championed by figures like Dan Jørgensen.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.